Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 160   

Articles published

AZN 5,184.83 +27.83 (0.54%)
price chart
AstraZeneca up after diabetes combo passes phase III
Astra's Elisabeth Bj�rk added: “With DURATION-8, AstraZeneca is the first company to highlight the results of combining a GLP-1 receptor agonist and SGLT-2 inhibitor as a potential treatment alternative to existing non-insulin therapies for patients ...
AstraZeneca plc (LON:AZN) Shares Lifted On Promising Type-2 Diabetes Drug ...  Simply Wall St
AstraZeneca Diabetes Drug Combination Shows Promise in Study  Bloomberg
Analysts Upgrade: AstraZeneca plc (ADR) (NYSE:AZN)
AstraZeneca plc (ADR) (NYSE:AZN) received a stock rating upgrade from Argus on Aug-29-16. In a note to investors, the firm issued a Buy rating.
AstraZeneca plc (ADR) (AZN) Stock Upgraded to Buy: Argus  TCC
Price Target Analysis: Astrazeneca PLC (NYSE:AZN)  News Oracle
Avara Acquires AstraZeneca Plc (NYSE:AZN) UK Manufacturing Plant
U.S. CMO Avara Pharmaceutical Service has announced that it has entered into an agreement under which it will acquire an AstraZeneca Plc (NYSE:AZN) manufacturing facility located in Avlon Avonmouth, England. Avara noted that it will hire 210 employees ...
Here's The Cause Of AstraZeneca Plc (NYSE:AZN) $5.5 Million Regulatory Slap
U.S. regulators have slapped AstraZeneca Plc (NYSE:AZN) with a $5.52 million bill stemming from investigations that found the company in the wrong over violation of the Foreign Corrupt Practices Act.
AstraZeneca to pay $5.52 million to resolve SEC foreign bribery case  Reuters
AstraZeneca Agrees to Pay $5.5 Million to Settle Alleged Bribery Probe  Wall Street Journal
Important Analyst Opinions about Stocks Earnings: Astrazeneca PLC (NYSE:AZN ...
Astrazeneca PLC (NYSE:AZN) surged +1.57% and ended at $34.28. The stock's market capitalization arrived at $86.73B and total traded volume was 4.55 million shares.
AstraZeneca Withdraws EU Application for Ovarian-Cancer Therapy
AstraZeneca Plc said it is withdrawing an application for European approval for an ovarian-cancer medicine following disagreement with regulatory authorities.
Can AstraZeneca plc (ADR) (AZN) Wipe out Bribery Smudge?
AstraZeneca plc (ADR) (NYSE:AZN) has to pay an amount of $5.52 million due to its involvement in the bribery case for making illegal payments to the healthcare officials in China and Russia by its sales staff in order to generate more business.
It's Earnings Time: What to Do with AstraZeneca PLC (NYSE:AZN) Stock  The Voice Registrar
New Broker Ratings For Astrazeneca PLC (NYSE:AZN)  FTSE News
AstraZeneca asthma treatment does well in final trial
A new AstraZeneca (LON:AZN) treatment generated significant improvements for severe asthma sufferers in its final trial, the pharma giant revealed today.
Will AstraZeneca plc's (ADR) (AZN) Asthma Molecule Diminish Patent Cliff ...  TCC
AstraZeneca's Asthma Injection Helps Lungs in Advanced Tests  Bloomberg
AstraZeneca plc's (AZN) "Hold" Rating Reiterated at Liberum Capital
AstraZeneca plc logo AstraZeneca plc (LON:AZN)'s stock had its “hold” rating reaffirmed by investment analysts at Liberum Capital in a research report issued to clients and investors on Tuesday.
AstraZeneca plc's (AZN) Hold Rating Reaffirmed at Liberum Capital  BBNS
Recent Trading Updates: Astrazeneca PLC (NYSE:AZN)
Astrazeneca PLC (NYSE:AZN) closed with decline of -0.89% to $33.52. Recent traded volume was 3.33 million shares versus to it an average volume of 6.19 million shares.
Analyst Review on Buzzer: Astrazeneca PLC (NYSE:AZN)  WsNews 4investors